Shuchun Chen

348 Heping West Road
Shijiazhuang, 050051, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 15 publications

Metabolic and hepatic effects of semaglutide and empagliflozin on metabolic dysfunction-associated steatotic liver disease mice.

Metabolic and hepatic effects of semaglutide and empagliflozin on metabolic dysfunction-associated steatotic liver disease mice.

Journal: World journal of hepatology

Published: June 05, 2025

Predictive value of asprosin combined with LAP for metabolic dysfunction associated steatotic liver disease in the physical examination population.

Predictive value of asprosin combined with LAP for metabolic dysfunction associated steatotic liver disease in the physical examination population.

Journal: Scientific reports

Published: April 12, 2025

Semaglutide and adenosine alleviate obesity-induced kidney injury, with observed modulation of the Txnip/NLRP3 pathway.

Semaglutide and adenosine alleviate obesity-induced kidney injury, with observed modulation of the Txnip/NLRP3 pathway.

Journal: Diabetology & metabolic syndrome

Published: January 29, 2025

Semaglutide attenuates lipotoxicity-induced cardiac injury by inhibiting Slc27a2 expression.

Semaglutide attenuates lipotoxicity-induced cardiac injury by inhibiting Slc27a2 expression.

Journal: Chemico-biological interactions

Published: January 04, 2025

Liraglutide combined with HIIT preserves contractile apparatus and blunts the progression of heart failure in diabetic cardiomyopathy rats.

Liraglutide combined with HIIT preserves contractile apparatus and blunts the progression of heart failure in diabetic cardiomyopathy rats.

Journal: Scientific reports

Published: June 12, 2024

Semaglutide ameliorates obesity-induced cardiac inflammation and oxidative stress mediated via reduction of neutrophil Cxcl2, S100a8, and S100a9 expression.

Semaglutide ameliorates obesity-induced cardiac inflammation and oxidative stress mediated via reduction of neutrophil Cxcl2, S100a8, and S100a9 expression.

Journal: Molecular and cellular biochemistry

Published: April 19, 2023

Triglyceride-glucose index and cervical vascular function: outpatient-based cohort study.

Triglyceride-glucose index and cervical vascular function: outpatient-based cohort study.

Journal: BMC endocrine disorders

Published: March 29, 2023

Effect of high-fat diet and empagliflozin on cardiac proteins in mice.

Effect of high-fat diet and empagliflozin on cardiac proteins in mice.

Journal: Nutrition & metabolism

Published: June 15, 2022

The relationship between estimated glucose disposal rate and bone turnover markers in type 2 diabetes mellitus.

The relationship between estimated glucose disposal rate and bone turnover markers in type 2 diabetes mellitus.

Journal: Endocrine

Published: February 22, 2022

Effects of Liraglutide on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Effects of Liraglutide on Nonalcoholic Fatty Liver Disease in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

Journal: Diabetes therapy : research, treatment and education of diabetes and related disorders

Published: March 22, 2021

β-catenin mediates the effect of GLP-1 receptor agonist on ameliorating hepatic steatosis induced by high fructose diet.

β-catenin mediates the effect of GLP-1 receptor agonist on ameliorating hepatic steatosis induced by high fructose diet.

Journal: European journal of histochemistry : EJH

Published: July 14, 2020

Impact of activating transcription factor 4 signaling on lipogenesis in HepG2 cells.

Impact of activating transcription factor 4 signaling on lipogenesis in HepG2 cells.

Journal: Molecular medicine reports

Published: May 31, 2015

Showing 1-12 of 15

Last Updated: 09/26/2026